Investor Stock List
Ranked #7,502 of 8,699 institutional investors

GordonMD Global Investments LP

Beverely Hills, CA

$129M
US stock portfolio at live prices · today +$1.1M (+0.84%)
Live prices, last trade 12:09 PM ET
Value at quarter end (Q3 2026)
$161M
Change from Q2 2026
−$25.6M (−13.68%)
Positions
13 · 2 new, 3 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$15.0M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PYXS 22.4%KYTX 15.0%BLCO 7.26%TNGX 6.19%CLDX 5.97%
StockSharesValue, live% of portfoliovs Q2 2026
PYXS Pyxis Oncology, Inc.15,541,909$28.8M22.4%Added +55%
KYTX Kyverna Therapeutics, Inc.4,521,318$19.4M15.0%Added +7%
BLCO Bausch + Lomb Corporation475,472$9.4M7.26%Reduced −17%
TNGX Tango Therapeutics, Inc.361,589$8.0M6.19%New
CLDX Celldex Therapeutics, Inc.279,720$7.7M5.97%Unchanged
VIR Vir Biotechnology, Inc.803,552$6.9M5.38%Reduced −41%
AMGN Amgen Inc.14,512$6.4M4.95%Reduced −28%
ADRX ADARx Pharmaceuticals, Inc.450,000$6.2M4.80%New
INCY Incyte Corporation51,080$5.9M4.58%Added +18%
SRRK Scholar Rock Holding Corporation110,500$5.6M4.34%Reduced −17%
EDIT Editas Medicine, Inc.3,127,000$5.4M4.16%Unchanged
ALLO Allogene Therapeutics, Inc.5,298,000$3.4M2.64%Unchanged
TSHA Taysha Gene Therapies, Inc.248,000$928K0.72%Reduced −66%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
RARE Ultragenyx Pharmaceutical Inc.289,101$4.8M
INSM Insmed Incorporated28,587$4.2M
SION Sionna Therapeutics, Inc.136,000$390K